Back
Can Fite Biofarma Stock Price Chart
Sponsored
CANF
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
CANF
Can Fite Biofarma
Last Price:
$1.44
Seasonality Move:
-5.63%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight selling pressure.
Can Fite Biofarma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.46 | Sell |
20-day SMA: | 1.67 | Sell |
50-day SMA: | 2.04 | Sell |
200-day SMA: | 2.36 | Sell |
8-day EMA: | 1.48 | Sell |
20-day EMA: | 1.63 | Sell |
50-day EMA: | 1.89 | Sell |
200-day EMA: | 2.3 | Sell |
Can Fite Biofarma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 33.71 | Sell |
Chaikin Money Flow: | -48330 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.46 - 2.02) | Sell |
Bollinger Bands (100): | (1.8 - 2.54) | Sell |
Can Fite Biofarma Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Can Fite Biofarma Stock
Is Can Fite Biofarma Stock a Buy?
-
Can Fite Biofarma share price is 1.43 while CANF 8-day simple moving average is 1.46, which is a Sell signal.
-
The stock price of CANF is 1.43 while Can Fite Biofarma 20-day SMA is 1.67, which makes it a Sell.
-
Can Fite Biofarma 50-day simple moving average is 2.04 while CANF share price is 1.43, making it a Sell technically.
-
CANF stock price is 1.43 and Can Fite Biofarma 200-day simple moving average is 2.36, creating a Sell signal.
CANF Technical Analysis vs Fundamental Analysis
Sell
29
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy or a Sell?
-
Can Fite Biofarma stock is rated a SellThe current Can Fite Biofarma [CANF] share price is $1.43. The Score for CANF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Can Fite Biofarma Stock Info
Market Cap:
8.7M
Price in USD:
1.43
Share Volume:
102.8K
Can Fite Biofarma 52-Week Range
52-Week High:
4.69
52-Week Low:
1.29
Sell
29
Can Fite Biofarma (CANF)
is a Sell
Can Fite Biofarma Share Price Forecast
-
What is the Can Fite Biofarma stock price today?The Can Fite Biofarma stock price is 1.43 USD today.
-
Will CANF stock go up or go down?Can Fite Biofarma> share price is forecast to RISE/FALL based on technical indicators
-
Is Can Fite Biofarma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Can Fite Biofarma is overvalued.
Is Can Fite Biofarma Stock a Buy?
-
Can Fite Biofarma share price is 1.43 while CANF 8-day exponential moving average is 1.48, which is a Sell signal.
-
The stock price of CANF is 1.43 while Can Fite Biofarma 20-day EMA is 1.63, which makes it a Sell.
-
Can Fite Biofarma 50-day exponential moving average is 1.89 while CANF share price is 1.43, making it a Sell technically.
-
CANF stock price is 1.43 and Can Fite Biofarma 200-day simple moving average is 2.30, creating a Sell signal.
Fundamental Analysis of Can Fite Biofarma
Is Can Fite Biofarma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Can Fite Biofarma
Should I short Can Fite Biofarma stock?
-
CANF Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Can Fite Biofarma is a Sell
-
Can Fite Biofarma Relative Strength Index (RSI) is 33.71, which suggest Can Fite Biofarma is oversold
-
The Bollinger Bands (25) for Can Fite Biofarma is (1.46 - 2.02), which suggest Can Fite Biofarma is a Sell
-
The Bollinger Bands (100) for Can Fite Biofarma is (1.8 - 2.54), which suggest Can Fite Biofarma is a Sell
* Can Fite Biofarma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.